ACTRN12616000473460招募中2 期
Efficacy of D-Cycloserine in combination with intensive exposure therapy in the treatment of obsessive compulsive disorder (OCD) in children
Dr Lara Farrell0 个研究点目标入组 80 人开始时间: 2016年4月11日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 7 Years 至 17 Years（—）
- 性别
- All
入选标准
- •Inclusion criteria -
- •(a) primary diagnosis of OCD with score of at least 16 on CYBOCS at pre- (moderate range)
- •(b) aged 7-17 years
- •(c) at least one parent willing to attend
- •(d) suspected IQ within at least average range and ability to understand cognitive components of treatment -
- •IQ will not be formally assessed in this project. Rather, this will be based on parent report of children’s general intellectual functioning during intake screening, and will involve asking the parent if they consider their child’s intellectual functioning to be at least in the low average range for children his/her age and they could understand general cognitive components of treatment.
- •(e) willingness to cease any other concurrent psychotherapy related to OCD treatment
- •(f) If taking psychotropic medication the following stabilization periods need to be completed prior to study entry
- •*If SSRI stable for 12 weeks prior to entering the study
- •* 6 weeks stable for ADHD or atypical antipsychotics
- •* Dose increases need to be stable for 8 weeks
- •*Dose decrease needs to be stable for 8 weeks
- •(g) willingness to keep mediation stable for the duration of the project, unless under medical advice to change dose or medication
排除标准
- •Exclusion criteria include -
- •(a) diagnosis of a Level 2 or 3 Autistic Spectrum Disorder based on newly revised DSM-V criteria
- •(b) Current suicidal ideation and risk or/evidence of intent.
- •Children with OCD are often extremely distressed by their condition, and whilst they may not be depressed and at risk of suicide based on our risk assessment, they may well express some thoughts of suicide. We routinely screen for risk, as does our independent Psychiatrist who screens all children, and as is current professional standards, deem them NOT at immediate risk if there is no intent - that is, if they have not thought about a plan to hurt themselves, and report no plan to actually act on their thoughts.
- •(c) intellectual impairment or previously diagnosed learning disorder (d) psychosis
- •(e) organic mental disorder
- •(f) other medications that are contraindicated with DCS
- •(g) pregnancy (will be screened for and if sexually active be required to use birth control)
- •(h) epilepsy or history of seizure
- •(i) history other serious medical condition that would be contraindicated with DCS (ie., cardiovascular, liver , kidney, respiratory etc),
- •(j) concurrent psychotherapy related to OCD treatment
- •(k) current diagnosis of Tuberculosis
- •(l) currently taking clozapine, or medication that lowers seizure threshold
- •(m) Significant substance abuse/use (e.g., Illegal drugs and Alcohol) defined as any ongoing (i.e., at least once a month on more than 2 occasions) use of alcohol or any illegal substance use.
- •(n) suspected diagnosis of PANDAS type OCD or current PANDAS diagnosis - Children will be referred to private psychiatrist for management as CBT is contraindicated for these youth.
研究者
相似试验
已完成
2 期
The efficacy of D-Cycloserine and psychotherapy on symptoms improvement in the adults with anxietyAnxiety Disorders.Anxiety disorder, unspecifiedIRCT2012071610297N1Isfahan University of Medical Sciences, School of Medicine, Vice Chancellor for Research36
尚未招募
2 期
The effect of the addition of D-cycloserine to exposure sessions in the treatment of patients with obsessive-compulsive disorder.10002861Obsessive-compulsive disorderNL-OMON30642Meerkanten GGZ (Ermelo)40
进行中（未招募）
不适用
The effect of the addition of D-cycloserine to exposure sessions in the treatment of patients with obsessive-compulsive disorder. A randomized, placebo-controlled trial.Obsessive-Compulsive DisorderEUCTR2007-000367-18-NLMeerkanten GGz
已完成
2 期
D-cycloserine for numbing and avoidance in chronic PTSDPost-traumatic stress disorderIRCT2013121015741N1Isafahan Univaersity of Medical Sciences, Deputy of Research76
已完成
不适用
D-cycloserine-supported exposure in patients with panic disorderISRCTN44960833Charite - University Medicine Berlin (Charite - Universitatsmedizin Berlin) (Germany)44